Literature DB >> 23642719

Cryptogenic sensory polyneuropathy.

Mamatha Pasnoor1, Mazen M Dimachkie, Richard J Barohn.   

Abstract

Chronic sensory or sensorimotor polyneuropathy is a common cause for referral to neurologists. Despite extensive diagnostic testing, up to one-third of these patients remain without a known cause, and are referred to as having cryptogenic sensory peripheral neuropathy. Symptoms progress slowly. On examination, there may be additional mild toe flexion and extension weakness. Electrophysiologic testing and histology reveals axonal neuropathy. Prognosis is usually favorable, as most patients maintain independent ambulation. Besides patient education and reassurance, management is focused on pharmacotherapy for neuropathic pain and physical therapy for balance training, and, occasionally, assistive devices.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23642719      PMCID: PMC4090929          DOI: 10.1016/j.ncl.2013.01.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  61 in total

1.  Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG).

Authors: 
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

2.  Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication.

Authors:  C A Wise; C A Garcia; S N Davis; Z Heju; L Pentao; P I Patel; J R Lupski
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

3.  Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients.

Authors:  N C Notermans; J H Wokke; H Franssen; Y van der Graaf; M Vermeulen; L H van den Berg; P R Bär; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

4.  Cryptogenetic polyneuropathies: an out-patient follow-up study.

Authors:  F Grahmann; M Winterholler; B Neundörfer
Journal:  Acta Neurol Scand       Date:  1991-09       Impact factor: 3.209

5.  Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.

Authors:  D G Savage; J Lindenbaum; S P Stabler; R H Allen
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

Review 6.  Peripheral neuropathies associated with monoclonal proteins.

Authors:  E P Bosch; B E Smith
Journal:  Med Clin North Am       Date:  1993-01       Impact factor: 5.456

7.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.

Authors:  N C Notermans; J H Wokke; H M Lokhorst; H Franssen; Y van der Graaf; F G Jennekens
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

8.  Chronic idiopathic axonal polyneuropathy: a five year follow up.

Authors:  N C Notermans; J H Wokke; Y van der Graaf; H Franssen; G W van Dijk; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

9.  Idiopathic distal small fiber neuropathy.

Authors:  K C Gorson; A H Ropper
Journal:  Acta Neurol Scand       Date:  1995-11       Impact factor: 3.209

Review 10.  Quantitative sensory testing: methodology, applications, and future directions.

Authors:  G Gruener; P J Dyck
Journal:  J Clin Neurophysiol       Date:  1994-11       Impact factor: 2.177

View more
  6 in total

1.  Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Authors:  Byron J Gajewski; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen Dimachkie; Laura Herbelin; Richard Barohn
Journal:  Stat Med       Date:  2015-01-07       Impact factor: 2.373

Review 2.  Polyneuropathies.

Authors:  Claudia Sommer; Christian Geber; Peter Young; Raimund Forst; Frank Birklein; Benedikt Schoser
Journal:  Dtsch Arztebl Int       Date:  2018-02-09       Impact factor: 5.594

Review 3.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

4.  Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment.

Authors:  Elisabeth Chroni; Dimitra Veltsista; Evangelia Gavanozi; Tavitha Vlachou; Panagiotis Polychronopoulos; Panagiotis Papathanasopoulos
Journal:  BMC Neurol       Date:  2015-03-11       Impact factor: 2.474

5.  A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.

Authors:  Alexandra R Brown; Byron J Gajewski; Lauren S Aaronson; Dinesh Pal Mudaranthakam; Suzanne L Hunt; Scott M Berry; Melanie Quintana; Mamatha Pasnoor; Mazen M Dimachkie; Omar Jawdat; Laura Herbelin; Richard J Barohn
Journal:  Trials       Date:  2016-08-31       Impact factor: 2.279

Review 6.  Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2019-12-01       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.